West Nile Virus News and Research

Latest West Nile Virus News and Research

Human protein may help prevent H1N1 infection

Howard Hughes Medical Institute researchers have identified a naturally occurring human protein that helps prevent infection by H1N1 influenza and other viruses, including West Nile and dengue virus.

18 Dec 2009

Flu-fighting proteins found in human cells stop flu virus, uncover scientists

In findings that may lead to better ways to prevent and treat influenza and other viral infections, researchers report the discovery of a family of naturally occurring antiviral agents in human cells.

18 Dec 2009

University of Alberta researchers make math and science real for high-school students

University of Alberta education professor Stephen Norris and mathematics professor Gerda de Vries used the virus as a theoretical tool when they designed materials for use in an advanced high-school math course.

15 Dec 2009

West Nile Virus can become more widespread in Europe than previously thought, says new report

Potentially fatal mosquito-borne West Nile fever (WNF) can become much more widespread in Europe than previously thought, say scientists in a new report just out in the journal BMC Evolutionary Biology(1).

8 Dec 2009

People infected with West Nile virus may have persistent virus in their kidneys, shows study

A new study shows that people who have been infected with West Nile virus may have persistent virus in their kidneys for years after initial infection, potentially leading to kidney problems.

8 Dec 2009

Habitat destruction and biodiversity loss can increase the incidence of infectious diseases

The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with McDonald's burgers.

4 Dec 2009

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

Roche announced today that the United States Food & Drug Administration (FDA) approved an additional intended use for its licensed nucleic acid test, to screen source plasma in pools comprised of up to 96 individual donations. The test, called the cobas® TaqScreen MPX Test for use on the cobas s 201 system, is a qualitative, in-vitro test for the simultaneous, direct detection of the human immunodeficiency virus (HIV-1 Group M RNA, HIV-1 Group O RNA , HIV-2 RNA), hepatitis C virus RNA and hepatitis B virus DNA in human plasma.

From Roche Sequencing and Life Science 2 Dec 2009

Americans living in the Southern region may have elevated risk of dying from stroke

The "stroke belt" has a tight hold. People born in the Southern stroke belt have a higher risk of dying from stroke as adults, even if they later move away, compared to people who were born in other parts of the country.

1 Dec 2009

Researchers to discover new vaccine against infection from Lyme disease

A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites.

20 Nov 2009

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa Influenza A H1N1 (2009) test developed by its Focus Diagnostics business has been CE marked and is now available as a test kit for distribution to approximately 35 countries in Europe.

From Quest Diagnostics 18 Nov 2009

FDA's BPAC renders positive opinion on Phase III clinical trial of INTERCEPT Blood System

Cerus Corporation announced today that the FDA's Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.

17 Nov 2009

Third-quarter 2009 results announced by Response Biomedical

Response Biomedical Corporation today announced financial results for the third quarter and nine months ended September 30, 2009.

10 Nov 2009

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of a larger $13 million award to the University of Washington.

10 Nov 2009

One Health Commission summit to focus on emerging infectious diseases

The growing threat of the H1N1 pandemic and West Nile virus -- as well as other emerging zoonotic, food, or waterborne diseases and environmental changes -- has prompted experts to look for solutions to the increasingly integrated problems among animal, human, and environmental health.

5 Nov 2009

Five-year program aimed at preventing future pandemic diseases awarded to DAI

DAI has been awarded a five-year program aimed at preventing future pandemics such as HIV/AIDS and H1N1.

30 Oct 2009

Avisio signs agreement to commercialize Instant Detect diagnostic technology

Avisio, Inc. announces the signing of a definitive agreement to commercialize Instant Detect, a portable nano-based diagnostic technology. Avisio, a publicly-traded commercialization company with a mission to unlock the value of high-potential assets and transform them into high-value businesses, now has the worldwide license to commercialize Instant Detect's ground-breaking portable diagnostic sensory technology.

28 Oct 2009

Mosquitoes are attracted by naturally produced, dominant odor in humans

Scientists at the University of California, Davis, have identified the dominant odor naturally produced in humans and birds that attracts the blood-feeding Culex mosquitoes, which transmit West Nile virus and other life-threatening diseases.

27 Oct 2009

Diabetes decreases cognitive decline in people with Alzheimer's disease

New research published in the October 27, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology, suggests that those with both diseases actually have a slower rate of memory loss than people who had only Alzheimer's disease.

27 Oct 2009

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company’s RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.

22 Oct 2009

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.

19 Oct 2009

West Nile Virus News and Research

Latest West Nile Virus News and Research

Human protein may help prevent H1N1 infection

Flu-fighting proteins found in human cells stop flu virus, uncover scientists

University of Alberta researchers make math and science real for high-school students

West Nile Virus can become more widespread in Europe than previously thought, says new report

People infected with West Nile virus may have persistent virus in their kidneys, shows study

Habitat destruction and biodiversity loss can increase the incidence of infectious diseases

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

Americans living in the Southern region may have elevated risk of dying from stroke

Researchers to discover new vaccine against infection from Lyme disease

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

FDA's BPAC renders positive opinion on Phase III clinical trial of INTERCEPT Blood System

Third-quarter 2009 results announced by Response Biomedical

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

One Health Commission summit to focus on emerging infectious diseases

Five-year program aimed at preventing future pandemic diseases awarded to DAI

Avisio signs agreement to commercialize Instant Detect diagnostic technology

Mosquitoes are attracted by naturally produced, dominant odor in humans

Diabetes decreases cognitive decline in people with Alzheimer's disease

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

West Nile Virus News and Research

Latest West Nile Virus News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in